// App-Quantinova.ai

: - Antibodies matter: A meta-analysis of the prognostic value of human equilibrative nucleoside transporter 1 (hENT1) antibodies in pancreatobiliary cancer

Researchers

Presenter

  • D.Yusuf

Principal Investigators

  • L.Vos

  • A.Lui

  • Z.Abdelaziz

  • S.Ghosh

  • J.Spratlin

  • J.Mackey

Medical Centers

  • Cross Cancer Institute, Edmonton, AB, Canada

  • Cross Cancer Institute, Edmonton, AB, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Gemcitabine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved